A detailed history of Baldwin Brothers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 9,960 shares of ABBV stock, worth $1.77 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
9,960
Previous 6,294 58.25%
Holding current value
$1.77 Million
Previous $1.08 Million 82.21%
% of portfolio
0.14%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $600,637 - $730,743
3,666 Added 58.25%
9,960 $1.97 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $4,643 - $5,422
-30 Reduced 0.47%
6,294 $1.08 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $71,119 - $81,034
-445 Reduced 6.57%
6,324 $1.15 Million
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $112,419 - $126,610
-817 Reduced 10.77%
6,769 $1.05 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $917,496 - $1.06 Million
-6,868 Reduced 47.52%
7,586 $1.13 Million
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $367,074 - $440,218
2,654 Added 22.49%
14,454 $0
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $141,591 - $162,396
-1,055 Reduced 8.21%
11,800 $1.58 Million
Q1 2022

Apr 13, 2022

BUY
$131.98 - $163.75 $1.03 Million - $1.28 Million
7,800 Added 154.3%
12,855 $2.08 Million
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $16,114 - $20,389
150 Added 3.06%
5,055 $684,000
Q4 2020

Jan 12, 2021

SELL
$80.49 - $108.67 $64,472 - $87,044
-801 Reduced 14.04%
4,905 $526,000
Q3 2020

Oct 16, 2020

SELL
$85.91 - $100.83 $3,006 - $3,529
-35 Reduced 0.61%
5,706 $500,000
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $24,163 - $30,233
335 Added 6.2%
5,741 $508,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $9,855 - $12,597
-150 Reduced 2.7%
5,406 $393,000
Q1 2019

Apr 24, 2019

SELL
$77.14 - $90.79 $3,008 - $3,540
-39 Reduced 0.7%
5,556 $448,000
Q4 2018

Feb 01, 2019

BUY
$77.85 - $96.01 $53,638 - $66,150
689 Added 14.04%
5,595 $516,000
Q2 2018

Jul 24, 2018

BUY
$89.78 - $106.23 $13,467 - $15,934
150 Added 3.15%
4,906 $455,000
Q1 2018

Apr 16, 2018

SELL
$92.01 - $123.21 $51,433 - $68,874
-559 Reduced 10.52%
4,756 $450,000
Q4 2017

Jan 24, 2018

SELL
$89.56 - $98.21 $537 - $589
-6 Reduced 0.11%
5,315 $514,000
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $371,671 - $474,739
5,321
5,321 $473,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $314B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.